We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+4.58%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$18.3B
AUM Growth
+$2.74B
(+18%)
Cap. Flow
+$2.65B
Cap. Flow
% of AUM
14.52%
Top 10 Holdings %
Top 10 Hldgs %
8.78%
Holding
1,974
New
365
Increased
607
Reduced
559
Closed
443
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$390M |
| 2 |
Honeywell
HON
|
+$158M |
| 3 |
Snap
SNAP
|
+$147M |
| 4 |
Citigroup
C
|
+$130M |
| 5 |
Mercado Libre
MELI
|
+$117M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$135M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$127M |
| 3 |
Verizon
VZ
|
+$121M |
| 4 |
Elevance Health
ELV
|
+$98.1M |
| 5 |
Abbott
ABT
|
+$89.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.4% |
| 2 | Consumer Discretionary | 13.55% |
| 3 | Industrials | 13.46% |
| 4 | Financials | 13.19% |
| 5 | Healthcare | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Centrus Energy
LEU
$3.83B
| $533K | ﹤0.01% |
+10,672
| New | +$594K |
|
|
MRSN
1402
DELISTED
Mersana Therapeutics
MRSN
| $526K | ﹤0.01% |
3,385
-473
| -12% | -$92K |
|
1403
O-I Glass
OI
$1.05B
| $525K | ﹤0.01% |
43,607
-6,608
| -13% | -$83.7K |
|
1404
AXIS Capital
AXS
$7.3B
| $517K | ﹤0.01% |
+9,488
| New | +$491K |
|
1405
Core Laboratories
CLB
$569M
| $517K | ﹤0.01% |
23,183
-37,629
| -62% | -$981K |
|
1406
Dorman Products
DORM
$3.95B
| $507K | ﹤0.01% |
4,483
-6,371
| -59% | -$692K |
|
|
SWTX
1407
DELISTED
SpringWorks Therapeutics
SWTX
| $505K | ﹤0.01% |
8,152
-4,826
| -37% | -$319K |
|
1408
Avista
AVA
$3.24B
| $499K | ﹤0.01% |
11,741
+1,559
| +15% | +$62.7K |
|
1409
Jazz Pharmaceuticals
JAZZ
$16B
| $493K | ﹤0.01% |
+3,873
| New | +$509K |
|
1410
Bank OZK
OZK
$5.7B
| $491K | ﹤0.01% |
10,563
-3,197
| -23% | -$146K |
|
1411
TTM Technologies
TTMI
$14.6B
| $489K | ﹤0.01% |
32,827
+22,024
| +204% | +$307K |
|
1412
Eagle Materials
EXP
$6.41B
| $486K | ﹤0.01% |
+2,922
| New | +$449K |
|
1413
Prelude Therapeutics
PRLD
$428M
| $486K | ﹤0.01% |
+39,014
| New | +$635K |
|
1414
RLI Corp
RLI
$5.87B
| $476K | ﹤0.01% |
+8,490
| New | +$460K |
|
1415
Bausch Health
BHC
$2.37B
| $473K | ﹤0.01% |
17,137
-418,398
| -96% | -$11.2M |
|
1416
LKQ Corp
LKQ
$6.38B
| $462K | ﹤0.01% |
+7,696
| New | +$434K |
|
1417
Morningstar
MORN
$7.76B
| $460K | ﹤0.01% |
1,346
-5,745
| -81% | -$1.78M |
|
1418
Beazer Homes USA
BZH
$874M
| $457K | ﹤0.01% |
19,674
-64,567
| -77% | -$1.3M |
|
1419
Ginkgo Bioworks
DNA
$488M
| $457K | ﹤0.01% |
+1,376
| New | +$654K |
|
1420
Curtiss-Wright
CW
$25.4B
| $449K | ﹤0.01% |
3,239
-1,535
| -32% | -$203K |
|
1421
Euronet Worldwide
EEFT
$2.78B
| $440K | ﹤0.01% |
3,693
-11,141
| -75% | -$1.32M |
|
|
EFOR
1422
Everforth Inc
EFOR
$1.37B
| $437K | ﹤0.01% |
+3,544
| New | +$433K |
|
1423
Regenxbio
RGNX
$704M
| $437K | ﹤0.01% |
13,372
-75,032
| -85% | -$2.55M |
|
1424
Universal Health Services
UHS
$10.1B
| $435K | ﹤0.01% |
+3,354
| New | +$431K |
|
1425
New Jersey Resources
NJR
$5.64B
| $430K | ﹤0.01% |
10,474
-6,806
| -39% | -$263K |
|
Similar funds
VAI
JG
OAG
Voloridge Investment Management's Q4 2021 Portfolio in Review
As of Q4 2021, Voloridge Investment Management held 1,974 positions worth $18.3B, up 18% from $15.5B the previous quarter. Its ten largest holdings account for 8.8% of the portfolio.
Voloridge Investment Management deployed $2.65B of net new capital in Q4 2021, opening 365 new positions and adding to 607 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 850,000 shares worth $404M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Micron Technology, an estimated $135M trimmed.
- Voloridge Investment Management's largest Q4 2021 buy was State Street SPDR S&P 500 ETF Trust: 850,000 shares worth $404M.
- Voloridge Investment Management added most to Honeywell in Q4 2021, an estimated $158M increase.
- Voloridge Investment Management's biggest Q4 2021 reduction was Micron Technology, cutting an estimated $135M.
- Voloridge Investment Management fully exited Abbott in Q4 2021, selling an estimated $89.9M.
- Voloridge Investment Management's ten largest holdings make up 8.8% of its $18.3B portfolio in Q4 2021.
- Voloridge Investment Management opened 365 new positions and closed 443 in Q4 2021.
- Voloridge Investment Management's portfolio value rose 18% quarter-over-quarter to $18.3B.
Based on Voloridge Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.